This presentation provides an overview of the Pin-point™ base editing platform with its novel three-part design and strong safety profile that enhances base editing's capabilities by enabling simultaneous modification of several genes at once, expanding its application in human disease modeling.
You will learn about:
The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.
The Pin-point™ platform: A novel modular base editing system